Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecular Pain is Scopus-indexed (Q1, CiteScore 5.1), WoS SCIE, DOAJ. Published by SAGE Publications Inc..
Checked against the index lists dated .
ISSN 1744-8069Verify ISSN ↗
Publisher: SAGE Publications Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Anesthesiology and Pain Medicine | 32 / 147 | 78th | Q1 |
| Molecular Medicine | 101 / 179 | 43rd | Q3 |
| Cellular and Molecular Neuroscience | 59 / 102 | 42nd | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2005–present, best quartile Q1, CiteScore 5.1.
Molecular Pain is Q1 in Anesthesiology and Pain Medicine (rank 32 of 147), Q3 in Molecular Medicine (rank 101 of 179) and Q3 in Cellular and Molecular Neuroscience (rank 59 of 102), by CiteScore 2025.
Molecular Pain is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.1, which places it in quartile Q1 at the 78th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.058, quartile Q1, with an H-index of 104.
The publisher lists an article processing charge of about US$2,650 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Molecular Pain is published by SAGE Publications Inc. Its ISSN is 1744-8069.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Molecular Pain has an h-index of 116 and a 2-year mean of 2.51 citations per paper (OpenAlex). Its Scopus CiteScore is 5.1, quartile Q1. On 2-year citations it ranks #30 of 145 Scopus journals in Anesthesiology and Pain Medicine.
Molecular Pain published 73 papers in 2025; its busiest recent year was 2018 with 109. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2025–2026), authors are most often from China (43.9%), United States (25.6%) and Japan (5.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 6 retracted papers are recorded (3.5 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.